Becker's Healthcare May 24, 2024
Cameron Cortigiano

An advisory committee to the FDA voted that a blood test that screens for colon and rectal cancers was safe, according to a May 23 report by The New York Times.

The test, designed by Guardant Health, offers an alternative to a colonoscopy or self-administered fecal test for individuals with an average risk for colon and rectal cancers.

However, blood tests are not as effective as colonoscopies at...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
Q&A: How Will the FDA Panel's Decision on MDMA Impact the Future of Psychedelic Medicine?
FDA approves 1st adult vaccine for bacterial pneumonia
FDA Approves Pneumococcal 21-Valent Conjugate Vaccine Capvaxive
FDA tells providers to prepare for supply chain disruptions

Share This Article